SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Stabilisation Notice

7 Sep 2017 09:34

RNS Number : 0984Q
J.P. Morgan Securities PLC.
07 September 2017
 

07th September 2017

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Nationwide Building Society ("Nationwide")

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/2016/1052 under the Market Abuse Regulation (EU/596/2014).

The securities:

Issuer:

Nationwide Building Society ("Nationwide")

Guarantor (if any):

N/A

Aggregate nominal amount:

£ TBC Core Capital Deferred Shares

 

Description:

Tap of Core Capital Deferred Shares ("CCDS") 10.25% Perp

 

Offer price:

TBC

Other offer terms:

Immediately fungible on ISIN- GB00BBQ33664

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

Merrill Lynch International (Stabilisation Manager)

Barclays Bank PLC (Stabilisation Manager)

Citigroup Global Capital Markets Limited (Stabilisation Manager)

UBS Limited (Stabilisation Manager)

Stabilisation period expected to start on:

7h September 2017

Stabilisation period expected to end no later than:

8th October 2017

Existence, maximum size and conditions of use of overallotment facility:

In connection with its stabilising activities Nationwide has granted J.P. Morgan, on behalf of the underwriters, an over-allotment option, exercisable, in whole or in part, at any time during the period commencing after the announcement of the Offer Price and ending on the business day falling immediately prior to the publication of the Prospectus, which if exercised, will require Nationwide to issue up to 15 per cent. of the aggregate number of CCDS available in the Offer (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of CCDS effected by it during the stabilising period.

J.P. Morgan has agreed with Nationwide that any over-allotment of CCDS by it or any of its agents will be up to a maximum of 15 per cent. of the total number of CCDS comprised in the Offer (before any exercise of the Over-allotment Option).

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities or effect other transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the day falling 30 calender days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAEAPNXEDFXEEF
Date   Source Headline
14th May 20195:43 pmRNSCCDS - Adjustment to PIR Cap
24th Apr 201912:00 pmRNSNotice of Redemption
8th Feb 20191:24 pmRNSPublication of Suppl.Prospcts
8th Feb 20197:00 amRNSInterim Management Statement 31 December 2018
11th Jan 201911:31 amRNSPublication of Final Terms
20th Dec 20182:45 pmRNSPublication of Suppl.Prospcts
18th Dec 20183:29 pmRNSPublication of a Prospectus
28th Nov 20186:02 pmRNSNationwide's Response to the Stress Test Results
22nd Nov 20181:24 pmRNSPublication of Suppl.Prospcts
22nd Nov 20187:00 amRNSNationwide Building Society - Interim Results 2018
19th Nov 20184:34 pmRNSRedemption of PIBS
14th Nov 20189:25 amRNSPublication of Final Terms
13th Nov 20189:53 amRNSPublication of Final Terms
13th Nov 20189:51 amRNSPublication of Final Terms
7th Nov 201810:07 amRNSPublication of Final Terms
31st Oct 20184:11 pmRNSPublication of a Prospectus
29th Oct 201811:09 amRNSPublication of Final Terms
23rd Oct 20187:00 amRNSPublication of Final Terms
4th Oct 20182:38 pmRNSPublication of Final Terms
1st Oct 20181:11 pmRNSAmendments to the Transaction Documents
14th Sep 20187:00 amRNSRedefining service for a digital world
10th Aug 20187:00 amRNSInterim Management Statement 30 June 2018
31st Jul 20183:25 pmRNSPublication of Final Terms
19th Jul 20183:35 pmRNSResult of AGM
26th Jun 20184:24 pmRNSNationwide - Publication of a Base Prospectus
23rd May 20182:23 pmRNSPublication of Supplementary Prospectus
22nd May 20187:00 amRNSPreliminary Results Announcement 2017/18
4th May 20189:40 amRNSPost Stab Notice Nationwide BS FR Cov Bds 2023
13th Apr 20183:34 pmRNSPublication of Final Terms
9th Apr 201810:20 amRNSPost-Stabilisation Notice - Nationwide 8nc7 SNP
5th Apr 20188:33 amRNSPre-Stab Notice Nationwide Building SocietyGBP FRN
16th Mar 201810:24 amRNSNotice of Redemption of PIBS
9th Mar 201811:55 amRNSResults of Tender Offer
9th Mar 20189:12 amRNSIndicative Results of Tender Offer
8th Mar 20182:46 pmRNSResults of Tender Offer
7th Mar 20184:43 pmRNSAnnouncement of Pricing pursuant to Tender Offer
7th Mar 201812:38 pmRNSPublication of Final Terms
6th Mar 20185:10 pmRNSPublication of Final Terms
1st Mar 201810:55 amRNSPre-Stabilisation Notice - Nationwide
28th Feb 20183:14 pmRNSUS Tender Offer
28th Feb 20183:13 pmRNSNon-US Tender Offer
28th Feb 20187:00 amRNSModification to 2018 Notes
28th Feb 20187:00 amRNSModification to 2023 Notes
20th Feb 20182:58 pmRNSNoteholder Meeting Results
16th Feb 20182:54 pmRNSPublication of a Prospectus
9th Feb 20183:55 pmRNSPublication of Suppl.Prospcts
9th Feb 20187:00 amRNSInterim Management Statement
6th Feb 20187:00 amRNSConsent Solicitation Early Consent Deadline
25th Jan 20188:50 amRNSConsent Solicitation
19th Jan 201810:43 amRNSNotice of Redemption

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.